Patent details

Basic Information

Publication number:

EP2288382

PCT Application Number:

IB2009005796

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097424592

PCT Publication Number:

WO2009136286

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI- IL-17A/IL-17F CROSS-REACTIVE ANTIBODIES AND METHODS OF USE THEREOF

French Title of Invention:

ANTICORPS À RÉACTION CROISÉE ANTI-IL-17A/IL-17F ET LEURS PROCÉDÉS D'UTILISATION

German Title of Invention:

ANTI IL-17A/IL-17F KREUZREAKTIVE ANTIKÖRPER UND DEREN VERWENDUNG

SPC Number:

Dates

Filing date:

05/05/2009

Grant date:

29/08/2018

EP Publication Date:

02/03/2011

PCT Publication Date:

12/11/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/08/2018

EP B1 Publication Date:

29/08/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/05/2019

Expiration date:

05/05/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/08/2018

 

 

Name:

NovImmune SA

Address:

14 ch. des Aulx 1228 Plan-Les-Ouates, Geneva, Switzerland (CH)

Inventor

1

Name:

MASTERNAK, Krzysztof

Address:

Switzerland (CH)

2

Name:

LEGER, Olivier

Address:

France (FR)

Priority

1

Priority Number:

126465 P

Priority Date:

05/05/2008

Priority Country:

United States (US)

2

Priority Number:

98369 P

Priority Date:

19/09/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; C07K 16/24;

Publication

European Patent Bulletin

Issue number:

201835

Publication date:

29/08/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages